Skip to main content
Funded Studies

Jyrki Mattila, MD, PhD

CEO at LZ Therapeutics, Inc.

Location: Malvern, PA United States


Associated Grants

  • Evaluation of the Effects of Human Cell Derived GM1 Ganglioside in the MPTP Lesioned Pre-clinical Model of Parkinson's Disease

    2012


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.